Search research articles
Contact Us
Filters
Showing results (31-40 of 381) with videos related to
Page
of 39
Sort By:
Nature Reviews. Rheumatology
|
September 6, 2019
Bedside to bench: defining the immunopathogenesis of psoriatic arthritis
Arlene Bravo, Arthur Kavanaugh
Experimental Cell Research
|
March 29, 2011
Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
Maja Mircic, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America
|
March 21, 2007
Rheumatic disease in the elderly: rheumatoid arthritis
Zuhre Tutuncu, Arthur Kavanaugh
Current Opinion in Rheumatology
|
May 18, 2013
Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors
Minyoung Her, Arthur Kavanaugh
Expert Opinion on Drug Safety
|
August 30, 2013
Adverse effects of golimumab in the treatment of rheumatologic diseases
Hong Yang, Arthur Kavanaugh
Expert Opinion on Pharmacotherapy
|
July 3, 2013
Psoriatic arthritis: current therapy and future directions
DoQuyen Huynh, Arthur Kavanaugh
Current Rheumatology Reports
|
December 23, 2019
Psoriatic Arthritis: Newer and Older Therapies
Robert Chao, Arthur Kavanaugh
Nature Reviews. Rheumatology
|
September 23, 2015
Clinical guidelines: Addressing comorbidities in systemic inflammatory disorders
Tristan Boyd, Arthur Kavanaugh
Clinical and Experimental Rheumatology
|
October 17, 2015
Interleukin-17 inhibition in psoriatic arthritis
Tristan Boyd, Arthur Kavanaugh
Expert Opinion on Biological Therapy
|
November 18, 2015
Novel approaches to biological therapy for psoriatic arthritis
Tristan Boyd, Arthur Kavanaugh
Page
of 39
Search research articles
Search
Showing results (31-40 of 381) with videos related to
Sort By:
Page
of 39
Nature Reviews. Rheumatology
|
September 6, 2019
Bedside to bench: defining the immunopathogenesis of psoriatic arthritis
Arlene Bravo, Arthur Kavanaugh
Experimental Cell Research
|
March 29, 2011
Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
Maja Mircic, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America
|
March 21, 2007
Rheumatic disease in the elderly: rheumatoid arthritis
Zuhre Tutuncu, Arthur Kavanaugh
Current Opinion in Rheumatology
|
May 18, 2013
Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors
Minyoung Her, Arthur Kavanaugh
Expert Opinion on Drug Safety
|
August 30, 2013
Adverse effects of golimumab in the treatment of rheumatologic diseases
Hong Yang, Arthur Kavanaugh
Expert Opinion on Pharmacotherapy
|
July 3, 2013
Psoriatic arthritis: current therapy and future directions
DoQuyen Huynh, Arthur Kavanaugh
Current Rheumatology Reports
|
December 23, 2019
Psoriatic Arthritis: Newer and Older Therapies
Robert Chao, Arthur Kavanaugh
Nature Reviews. Rheumatology
|
September 23, 2015
Clinical guidelines: Addressing comorbidities in systemic inflammatory disorders
Tristan Boyd, Arthur Kavanaugh
Clinical and Experimental Rheumatology
|
October 17, 2015
Interleukin-17 inhibition in psoriatic arthritis
Tristan Boyd, Arthur Kavanaugh
Expert Opinion on Biological Therapy
|
November 18, 2015
Novel approaches to biological therapy for psoriatic arthritis
Tristan Boyd, Arthur Kavanaugh
Page
of 39